| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | -2.06% | +1.55% | -3.62% | -3.07% | — |
| 14d | 3 | +100.00% | -5.61% | +0.87% | -6.48% | -7.08% | — |
| 30d | 3 | +66.67% | -3.82% | +4.88% | -8.70% | -4.81% | — |
| 60d | 3 | +33.33% | +2.05% | +7.74% | -5.69% | +0.71% | — |
| 90d | 3 | +100.00% | -12.22% | +7.36% | -19.58% | -17.82% | — |
| 180d | 3 | +100.00% | -17.28% | +16.59% | -33.86% | -40.44% | — |
| 1y | 3 | +100.00% | -12.26% | +23.65% | -35.91% | -36.28% | — |
| 2y | 3 | +100.00% | -61.55% | +8.31% | -69.85% | -71.75% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 16,278 | $6.84 | $111.3K | 116,361 | Mar 31, 2023 | Apr 4, 2023 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 131,323 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 3,602 | $10.26 | $37.0K | 91,323 | Jan 11, 2023 | Jan 12, 2023 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 3,602 | $9.85 | $35.5K | 94,925 | Jan 10, 2023 | Jan 12, 2023 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 5,437 | $9.87 | $53.7K | 98,527 | Jan 4, 2023 | Jan 6, 2023 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Jan 4, 2023 | Jan 6, 2023 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 3,458 | $12.85 | $44.4K | 103,963 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 3,583 | $14.36 | $51.5K | 107,421 | Jan 11, 2022 | Jan 12, 2022 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 4,150 | $14.30 | $59.3K | 111,004 | Jan 10, 2022 | Jan 12, 2022 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 115,154 | Jan 4, 2022 | Jan 6, 2022 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Jan 4, 2022 | Jan 6, 2022 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 73,386 | Apr 28, 2021 | Apr 30, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 114,240 | $16.25 | $1.86M | 53,386 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 20,312 | — | — | 4,688 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 24,356 | — | — | 0 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASE Chief Scientific Officer | 24,356 | $2.08 | $50.8K | 89,502 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 57,812 | — | — | 17,188 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASE Chief Scientific Officer | 57,812 | $10.05 | $581.0K | 167,626 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASE Chief Scientific Officer | 20,312 | $9.30 | $188.9K | 109,814 | Mar 9, 2021 | Mar 11, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Feb 1, 2021 | Feb 3, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 62,500 | — | — | 62,500 | Jan 11, 2021 | Jan 13, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 31,250 | — | — | 65,146 | Jan 11, 2021 | Jan 13, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 4,080 | $18.18 | $74.2K | 33,896 | Jan 10, 2021 | Jan 12, 2021 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 17,626 | $18.05 | $318.1K | 36,673 | Dec 10, 2020 | Dec 11, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASE Chief Scientific Officer | 17,626 | $2.08 | $36.7K | 54,299 | Dec 10, 2020 | Dec 11, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 17,626 | — | — | 24,356 | Dec 10, 2020 | Dec 11, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASE Chief Scientific Officer | 30,000 | $2.08 | $62.5K | 86,185 | Dec 9, 2020 | Dec 11, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 30,000 | — | — | 41,982 | Dec 9, 2020 | Dec 11, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 49,512 | $18.24 | $903.1K | 36,673 | Dec 9, 2020 | Dec 11, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | SALE Chief Scientific Officer | 3,477 | $17.73 | $61.6K | 24,935 | Jan 10, 2020 | Jan 14, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 8,900 | — | — | 28,412 | Jan 10, 2020 | Jan 14, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 62,500 | — | — | 62,500 | Jan 10, 2020 | Jan 14, 2020 ↗ | View → |
| CHRS COHERUS ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 31,250 | — | — | 56,185 | Jan 10, 2020 | Jan 14, 2020 ↗ | View → |